全文获取类型
收费全文 | 144903篇 |
免费 | 10644篇 |
国内免费 | 6119篇 |
专业分类
耳鼻咽喉 | 922篇 |
儿科学 | 2983篇 |
妇产科学 | 1043篇 |
基础医学 | 12108篇 |
口腔科学 | 3874篇 |
临床医学 | 20607篇 |
内科学 | 18727篇 |
皮肤病学 | 1170篇 |
神经病学 | 10795篇 |
特种医学 | 7258篇 |
外国民族医学 | 10篇 |
外科学 | 22350篇 |
综合类 | 26578篇 |
现状与发展 | 13篇 |
一般理论 | 2篇 |
预防医学 | 7225篇 |
眼科学 | 1767篇 |
药学 | 13588篇 |
94篇 | |
中国医学 | 6386篇 |
肿瘤学 | 4166篇 |
出版年
2024年 | 149篇 |
2023年 | 2142篇 |
2022年 | 3336篇 |
2021年 | 5498篇 |
2020年 | 5463篇 |
2019年 | 4533篇 |
2018年 | 4663篇 |
2017年 | 5074篇 |
2016年 | 5430篇 |
2015年 | 5294篇 |
2014年 | 10471篇 |
2013年 | 11936篇 |
2012年 | 9407篇 |
2011年 | 10109篇 |
2010年 | 8192篇 |
2009年 | 7686篇 |
2008年 | 7642篇 |
2007年 | 7667篇 |
2006年 | 7034篇 |
2005年 | 6116篇 |
2004年 | 4957篇 |
2003年 | 4313篇 |
2002年 | 3404篇 |
2001年 | 3076篇 |
2000年 | 2486篇 |
1999年 | 2086篇 |
1998年 | 1662篇 |
1997年 | 1534篇 |
1996年 | 1290篇 |
1995年 | 1189篇 |
1994年 | 1012篇 |
1993年 | 778篇 |
1992年 | 711篇 |
1991年 | 616篇 |
1990年 | 563篇 |
1989年 | 494篇 |
1988年 | 433篇 |
1987年 | 365篇 |
1986年 | 323篇 |
1985年 | 439篇 |
1984年 | 329篇 |
1983年 | 207篇 |
1982年 | 266篇 |
1981年 | 273篇 |
1980年 | 244篇 |
1979年 | 168篇 |
1978年 | 133篇 |
1977年 | 113篇 |
1976年 | 118篇 |
1975年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Oxidative stress and inflammation are two possible mechanisms related to nephrotoxicity caused by environmental pollutants. Ellagic acid, a powerful antioxidant phytochemical, may have great relevance in mitigating pollutant-induced nephrotoxicity and preventing the progression of kidney disease. This review discusses the latest findings on the protective effects of ellagic acid, its metabolic derivatives, the urolithins, against kidney toxicity caused by heavy metals, pesticides, mycotoxins, and organic air pollutants. We describe the chelating, antioxidant, anti-inflammatory, antifibrotic, antiautophagic, and antiapoptotic properties of ellagic acid to attenuate nephrotoxicity. Furthermore, we present the molecular targets and signaling pathways that are regulated by these antioxidants, and suggest some others that should be explored. Nevertheless, the number of reports is still limited to establish the efficacy of ellagic acid against kidney damage induced by environmental pollutants. Therefore, additional preclinical studies on this topic are required, as well as the development of well-designed clinical trials. 相似文献
22.
目的分析肝移植术后受者外周血CD19+CD24hiCD38hi B细胞占单个核细胞比例变化情况及其与急性细胞性排斥反应(ACR)之间的关系。 方法回顾性分析2013年12月至2015年12月在浙江大学医学院附属第一医院接受心脏死亡器官捐献肝移植的80例成人受者临床资料,根据术后是否发生ACR,将受者分为ACR组(25例)和非ACR组(55例)。术前、术后各个时间点抽取参加研究者静脉血并分离外周血单个核细胞,加入异硫氰酸荧光素-单克隆鼠抗人CD19抗体、藻红蛋白-单克隆鼠抗人CD24抗体和别藻蓝蛋白-单克隆鼠抗人CD38抗体,流式细胞仪检测各组CD19+CD24hiCD38hi B细胞百分比。采用t检验和单因素方差分析比较正态分布计量资料,采用χ2检验比较计数资料,采用Kaplan-Meier法绘制受试者工作特征曲线(ROC曲线)。P<0.05为差异有统计学意义。 结果ACR组、非ACR组受者术前外周血平均CD19+CD24hiCD38hi B细胞比例分别为(3.13±0.91)%、(3.49±0.83)%,差异无统计学意义(t=1.636,P>0.05)。ACR组术后发生ACR前外周血平均CD19+CD24hiCD38hi B细胞比例为(1.87±0.70)%。非ACR组受者术后3个月、6个月和1年外周血平均CD19+CD24hiCD38hi B细胞比例分别为(1.64±0.52)%、(1.63±0.56)%和(2.04±1.24)%,术后3、6个月平均值均低于术前和术后1年,差异均有统计学意义(P均<0.05)。ACR组受者发生ACR时外周血平均CD19+CD24hiCD38hi B细胞比例为(0.8±0.5)%,低于发生ACR前的平均水平(t=5.752,P<0.05),且低于非ACR组术后3个月、6个月和1年的平均水平(P<0.05)。ACR组受者接受抗排斥反应治疗后,CD19+CD24hiCD38hi B细胞比例也逐渐增加,ACR发生后7 d为(0.84±0.08)%,与ACR发生时相比差异无统计学意义(P>0.05);而发生30 d后达(1.65±0.18)%,与ACR发生时相比差异有统计学意义(P<0.05)。当截断值为1.015%时,CD19+CD24hiCD38hi B细胞比例预测ACR发生的敏感度和特异度分别为0.786和0.702,ROC曲线下面积为0.775(95%CI: 0.671~0.879,P<0.05)。 结论CD19+CD24hiCD38hi B细胞比例下降与肝移植术后ACR反应发生有关,并可作为预测ACR发生的细胞标志物。 相似文献
23.
24.
ObjectiveTo cross-culturally adapt and evaluate the psychometric properties of the University of Wisconsin Running Injury and Recovery Index questionnaire in Spanish (UWRI-S) in Chilean runners with a running-related injury.DesignCross-cultural adaptation and validation study, following the Consensus-based Standards for selecting health Measurement Instruments (COSMIN) recommendations.SettingOutpatient sports medicine clinic and running clubs.ParticipantsUWRI was forward and backward translated, and culturally adapted. Thirty-one runners participated in the content validity of the UWRI-S; and fifty-seven in the assessment of psychometric properties.Main outcome measuresRunners seeking care from a physiotherapist completed the UWRI-S (baseline and after 48–72 h for reliability), Lower Extremity Functional Scale (LEFS), Patient Specific Functional Scale (PSFS), Global Rating of Change scale (GROC), and Numeric Pain Rating Scale (NPRS).ResultsSuggestions about accuracy of wording and understanding of items were incorporated. UWRI-S showed a positive moderate correlation with LEFS (r = 0.6; p < 0.05), positive fair with GROC (r = 0.5, p < 0.05), negative fair with NPRS (r = −0.4; p < 0.05) and no correlation with PSFS (r = 0.3; p = 0.1). UWRI-S demonstrated acceptable internal consistency (α = 0.87) and test-retest reliability (ICC = 0.87).ConclusionUWRI-S is a valid and reliable measure to evaluate running ability of Chilean runners during recovery from a running-related injury. 相似文献
25.
《European journal of surgical oncology》2022,48(3):500-507
IntroductionThe aim of this study was to compare long-term patient reported outcomes (PROs) in patients with locally advanced extremity soft tissue sarcoma (eSTS) after isolated limb perfusion followed by resection (IR), compared to extended resection (ER), primary amputation (A) or secondary amputation after IR (IR-A).MethodsPatients were selected from the respondents of a multi-institutional cross-sectional cohort survivorship study (SURVSARC) conducted among sarcoma survivors registered in the Netherlands Cancer Registry (NCR), 2–10 years after diagnosis. Used PROs were the EORTC QLQ-C30, the Cancer worry scale (CWS), the Hospital Anxiety and Depression Scale (HADS), and the Toronto Extremity Salvage Score (TESS).ResultsWe identified 97 eSTS survivors: IR = 20, ER = 49, A = 20, IR-A = 8. While there were no differences in PROs between IR and ER, results showed better functioning and functionality in both groups versus the amputation groups. The amputation groups scored significantly lower on physical functioning (A = 62.7, IR-A = 65.7 versus IR = 78.0, ER = 82.7, p = 0.001) and role functioning (A = 67.5, IR-A = 52.8 versus IR = 79.2, ER = 80.6, p = 0.039), both EORTC QLQ-C30 scales. Also for the TESS, the scores were significantly lower for the amputation groups compared to the limb sparing groups (upper extremity p = 0.007 with A = 68.9, IR-A = 71.6 versus IR = 93.3, ER = 91.1; lower extremity p < 0.001 with A = 72.2, IR-A50.9 versus IR = 84.5 and ER = 85.5). There were no significant differences between the groups on cancer worry, anxiety and depression.ConclusionHRQoL in eSTS survivors treated with IR or ER is equal; for maintenance of physical functioning and functionality IR and ER outperform an amputation. 相似文献
26.
27.
28.
目的了解何首乌致药物性肝损伤(Polygonum multiflorum-associated drug induce liver injury,PM-DILI)的临床病理学特点。方法收集2019年3月1日至2021年3月1日深圳市第三人民医院收治的8例PM-DILI患者临床资料。肝穿组织进行苏木素-伊红染色、网状纤维染色、Masson三色染色、铁、铜特殊染色和免疫组织化学染色,显微镜下观察分析。结果8例PM-DILI患者男女比为1∶1,平均年龄43岁,其中6例为急性PM-DILI,2例慢性为PM-DILI。入院血清学检查异常主要包括转氨酶升高和淤胆均为7例。主要组织病理学改变为点灶状坏死8例、界面炎5例、融合坏死4例,融合坏死以肝腺泡3带为主,不伴或伴少数炎细胞浸润;胆汁淤积5例,为肝腺泡3带的肝细胞、毛细胆管内淤胆,不伴或伴少数炎细胞浸润;中央静脉炎3例;病程长者可发生肝纤维化,甚至肝硬化2例。结论肝腺泡3带为主的急性淤胆和肝细胞坏死是PM-DILI主要组织学表现,严重者可发生静脉炎等血管损伤。 相似文献
29.
30.
《Clinical Lymphoma, Myeloma & Leukemia》2022,22(3):174-191
BackgroundMost likely due to the availability of potential stem cell sources, there appears to be a growing usage of haploidentical (haplo) donors for cases of acute lymphoblastic leukemia involving high-risk features or relapse.Patients and MethodsThis study compared the outcomes of stem cell transplantations (SCTs) using haplo and other stem cell sources, namely, matched sibling donors (MSDs), matched unrelated donors (MUDs), and cord blood transplantations (CBTs). Literature searches were conducted of the MEDLINE and Embase databases from inception to December 2020.ResultsTwenty-eight studies were examined (17 retrospective and 11 prospective). There were no significant differences in the overall survival of haplo and those of the other stem-cell sources. For haplo versus matched donor (MSD or MUD), the pooled odds ratio (OR) was 0.94 (95% CI, 0.79-1.12; I2, 22%); while for haplo versus CBT, the OR was 1.24 (95% CI, 0.78-1.96; I2, 28%). The cumulative relapse incidence was significantly higher for MSD than haplo (OR, 0.69; 95% CI, 0.48-0.99; I2, 48%). Both grade II-IV acute and long-term graft-versus-host disease (GVHD) were significantly higher for haplo than MSD (OR, 1.78; 95% CI, 1.15-2.74; I2, 28%; and OR, 1.33; 95% CI, 1.00-1.77; I2, 14%, respectively). The other clinical outcomes did not demonstrate any statistical differences.ConclusionThe outcomes of patients treated with haplo-SCT appear comparable with those of the SCTs using other sources. The higher probability of developing GVHD supports the need for a novel method to harness T-cell alloreactivity 相似文献